Clinical trials
Body Weight trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 6 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
| Completed | 17 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| John Sievenpiper | 11 |
| University of Toronto | 9 |
| Pfizer | 3 |
| KGK Science Inc. | 2 |
| Laval University | 2 |
| Amgen | 1 |
| Centre for Addiction and Mental Health | 1 |
| Children's & Women's Health Centre of British Columbia | 1 |
| Concordia University, Montreal | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Body Weight | 48 |
| Obesity | 34 |
| Overweight | 21 |
| Diabetes Mellitus | 16 |
| Cardiovascular Diseases | 13 |
| Insulin Resistance | 10 |
| Prediabetic State | 10 |
| Diabetes Mellitus, Type 2 | 9 |
| Hypertension | 9 |
| Metabolic Syndrome | 9 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.